Beta Bionics (BBNX) leads innovation in the diabetes treatment market with its groundbreaking iLet Bionic Pancreas technology ...
Undoubtedly this is the start of an evolution towards a true 'artificial pancreas' which could transform treatment of diabetes. The first ever device to automatically monitor blood glucose and ...
Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...
A couple of significant breakthroughs available include islet autotransplantation and artificial pancreas. Islet autotransplantation involves transplanting islet cells (the specific pancreatic ...
When Ed Damiano’s infant son was diagnosed with Type 1 diabetes, Ed found his life’s work: inventing an artificial or “bionic” pancreas. “David has diabetes - our lives are changed ...
Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its artificial pancreas system for people with Type 1 diabetes. The California ...
With a new $1.2 million grant from the National Institutes of Health, Fiesler, Information Science Associate Professor Stephen Voida and collaborators from computer science and CU Anschutz hope to ...
The US-based company sold 12 million shares of its common stock for $17 each. The artificial pancreas maker had initially ...
Medtech company Senseonics has signed a deal with diabetes management startup TypeZero to develop a new artificial pancreas option. A wave of companies are looking to develop their own automated ...
For the first time, researchers have developed an artificial pancreas that can respond accurately to blood sugar levels and even predict the body’s insulin requirements. The system consists ...
An engineer by training and father of a son with diabetes, he is on a quest to build his version of an artificial pancreas, called the “bionic” pancreas. His story, featured in Blood Sugar ...
Our lab is dedicated to developing an artificial pancreas. This is an insulin dispensing device that responds to the body to deliver variable doses as an intelligent response to the blood glucose.